Dulcolax Simulant Laxative
NDC 41167-0101, Bisacodyl, tablet, film coated, from Chattem, Inc..
- Product NDC
- 41167-0101
- Status
- Listed
- Labeler
- Chattem, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- 505G(a)(3)
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/41167-0101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BISACODYL5 mg/1
Pharmacologic classes
Increased Large Intestinal Motility [PE]; Stimulant Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 41167-0101-0 | 41167010100 | 1 BLISTER PACK in 1 CARTON (41167-0101-0) / 8 TABLET, FILM COATED in 1 BLISTER PACK |
| 41167-0101-1 | 41167010101 | 1 BLISTER PACK in 1 CARTON (41167-0101-1) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| 41167-0101-2 | 41167010102 | 1 BLISTER PACK in 1 CARTON (41167-0101-2) / 25 TABLET, FILM COATED in 1 BLISTER PACK |
| 41167-0101-3 | 41167010103 | 2 BLISTER PACK in 1 CARTON (41167-0101-3) / 25 TABLET, FILM COATED in 1 BLISTER PACK |
| 41167-0101-4 | 41167010104 | 4 BLISTER PACK in 1 CARTON (41167-0101-4) / 25 TABLET, FILM COATED in 1 BLISTER PACK |
| 41167-0101-5 | 41167010105 | 8 BLISTER PACK in 1 CARTON (41167-0101-5) / 25 TABLET, FILM COATED in 1 BLISTER PACK |
| 41167-0101-6 | 41167010106 | 3 BLISTER PACK in 1 CARTON (41167-0101-6) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| 41167-0101-7 | 41167010107 | 1 BLISTER PACK in 1 CARTON (41167-0101-7) / 6 TABLET, FILM COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 41167-0101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/41167-0101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 41167-0101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.